LAFAYETTE, La., Oct. 4, 2018 /PRNewswire/ -- Patients suffering from chronic obstructive pulmonary disease (COPD) with chronic respiratory failure (CRF) using home non-invasive ventilation (NIV) live ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) announced today the results of two clinical analyses conducted for the U.K. and U.S., demonstrating the cost effectiveness of combining home ...
Today ResMed welcomed positive results from the independent Home Oxygen Therapy- Home Mechanical Ventilation (HOT-HMV) study regarding the benefits of home non-invasive ventilation (NIV). Portable ...
Chronic obstructive pulmonary disease (COPD) is a life-threatening condition that, according to the American Lung Association, affects around 16 million people in the United States 1. Sufferers have ...
New ResMed (RMD)-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results